NORTHRIDGE, Calif. (AP) — NORTHRIDGE, Calif. (AP) — Minimed Group Inc. (MMED) on Wednesday reported a loss of $183 million in its fiscal fourth quarter.
The Northridge, California-based company said it had a loss of 68 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.
The developer and maker of diabetes medical devices posted revenue of $837 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $827.8 million.
For the year, the company reported a loss of $331 million, or $1.29 per share. Revenue was reported as $3.1 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MMED at https://www.zacks.com/ap/MMED
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
